{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:44:58Z","timestamp":1791895498310,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.xcrm.2021.100326","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T10:40:02Z","timestamp":1624272002000},"page":"100326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies"],"prefix":"10.1016","volume":"2","author":[{"given":"Alexandra C.","family":"Willcox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex S.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ababacar","family":"Diouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan R.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Silk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd D.W.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.W.","family":"Alanine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahamadou","family":"Diakite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoyo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2021.100326_bib1","series-title":"World malaria report 2019","year":"2020"},{"key":"10.1016\/j.xcrm.2021.100326_bib2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature10606","article-title":"Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum","volume":"480","author":"Crosnier","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100326_bib3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-018-0779-6","article-title":"Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complex","volume":"565","author":"Wong","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100326_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chom.2016.06.004","article-title":"Essential role of the PfRh5\/PfRipr\/CyRPA complex during Plasmodium falciparum invasion of erythrocytes","volume":"20","author":"Volz","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2021.100326_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/infdis\/jit553","article-title":"Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria","volume":"209","author":"Tran","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100326_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4049\/jimmunol.1300778","article-title":"Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development","volume":"191","author":"Richards","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100326_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fmicb.2014.00314","article-title":"Association of antibodies to Plasmodium falciparum reticulocyte binding protein homolog 5 with protection from clinical malaria","volume":"5","author":"Chiu","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.xcrm.2021.100326_bib8","doi-asserted-by":"crossref","first-page":"33094","DOI":"10.1038\/srep33094","article-title":"The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria","volume":"6","author":"Weaver","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2021.100326_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.chom.2014.11.017","article-title":"A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys","volume":"17","author":"Douglas","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2021.100326_bib10","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/s41467-019-09894-4","article-title":"A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates","volume":"10","author":"Douglas","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2021.100326_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/ncomms1615","article-title":"The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody","volume":"2","author":"Douglas","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2021.100326_bib12","doi-asserted-by":"crossref","first-page":"e30251","DOI":"10.1371\/journal.pone.0030251","article-title":"Targeting sialic acid dependent and independent pathways of invasion in Plasmodium falciparum","volume":"7","author":"Ord","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100326_bib13","doi-asserted-by":"crossref","first-page":"e1002991","DOI":"10.1371\/journal.ppat.1002991","article-title":"Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens","volume":"8","author":"Williams","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2021.100326_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.vaccine.2012.10.106","article-title":"A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants","volume":"31","author":"Bustamante","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2021.100326_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/IAI.00970-13","article-title":"Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies","volume":"82","author":"Reddy","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.xcrm.2021.100326_bib16","doi-asserted-by":"crossref","first-page":"e13030","DOI":"10.1111\/cmi.13030","article-title":"Neutralising antibodies block the function of Rh5\/Ripr\/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes","volume":"21","author":"Healer","year":"2019","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.xcrm.2021.100326_bib17","doi-asserted-by":"crossref","first-page":"96381","DOI":"10.1172\/jci.insight.96381","article-title":"Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions","volume":"2","author":"Payne","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2021.100326_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2019.05.025","article-title":"Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies","volume":"178","author":"Alanine","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2021.100326_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41541-018-0071-7","article-title":"Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells","volume":"3","author":"Jin","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.xcrm.2021.100326_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medj.2021.03.014","article-title":"Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination","volume":"2","author":"Minassian","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.xcrm.2021.100326_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/14760584.2016.1141680","article-title":"Progress and prospects for blood-stage malaria vaccines","volume":"15","author":"Miura","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.xcrm.2021.100326_bib22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","article-title":"A field trial to assess a blood-stage malaria vaccine","volume":"365","author":"Thera","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100326_bib23","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.vaccine.2009.03.014","article-title":"A randomized controlled phase 2 trial of the blood stage AMA1-C1\/Alhydrogel malaria vaccine in children in Mali","volume":"27","author":"Sagara","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2021.100326_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.pt.2020.04.003","article-title":"The RH5-CyRPA-Ripr complex as a malaria vaccine target","volume":"36","author":"Ragotte","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.xcrm.2021.100326_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pt.2007.12.002","article-title":"Apical membrane antigen 1: a malaria vaccine candidate in review","volume":"24","author":"Remarque","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.xcrm.2021.100326_bib26","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.vaccine.2011.01.043","article-title":"Immunological responses against Plasmodium falciparum Apical Membrane Antigen 1 vaccines vary depending on the population immunized","volume":"29","author":"Miura","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2021.100326_bib27","doi-asserted-by":"crossref","first-page":"8776","DOI":"10.4049\/jimmunol.181.12.8776","article-title":"Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination","volume":"181","author":"Miura","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100326_bib28","doi-asserted-by":"crossref","first-page":"e20947","DOI":"10.1371\/journal.pone.0020947","article-title":"Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay","volume":"6","author":"Miura","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100326_bib29","doi-asserted-by":"crossref","first-page":"e0170948","DOI":"10.1371\/journal.pone.0170948","article-title":"High Plasmodium falciparum longitudinal prevalence is associated with high multiclonality and reduced clinical malaria risk in a seasonal transmission area of Mali","volume":"12","author":"Adomako-Ankomah","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100326_bib30","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1038\/ncomms14333","article-title":"P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5","volume":"8","author":"Galaway","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2021.100326_bib31","doi-asserted-by":"crossref","first-page":"247ra102","DOI":"10.1126\/scitranslmed.3008705","article-title":"New antigens for a multicomponent blood-stage malaria vaccine","volume":"6","author":"Osier","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2021.100326_bib32","doi-asserted-by":"crossref","first-page":"e0198371","DOI":"10.1371\/journal.pone.0198371","article-title":"Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria","volume":"13","author":"Partey","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100326_bib33","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.4049\/jimmunol.1103177","article-title":"Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen","volume":"188","author":"Dreyer","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100326_bib34","doi-asserted-by":"crossref","first-page":"12045","DOI":"10.1073\/pnas.1702944114","article-title":"Synergistic malaria vaccine combinations identified by systematic antigen screening","volume":"114","author":"Bustamante","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100326_bib35","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/infdis\/jit385","article-title":"Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans","volume":"208","author":"Patel","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100326_bib36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1475-2875-13-326","article-title":"A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein","volume":"13","author":"Ord","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.xcrm.2021.100326_bib37","doi-asserted-by":"crossref","first-page":"e21347","DOI":"10.7554\/eLife.21347","article-title":"Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA","volume":"6","author":"Chen","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2021.100326_bib38","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1073\/pnas.1415466112","article-title":"Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion","volume":"112","author":"Reddy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100326_bib39","doi-asserted-by":"crossref","first-page":"e20383","DOI":"10.7554\/eLife.20383","article-title":"Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody","volume":"6","author":"Favuzza","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2021.100326_bib40","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3389\/fimmu.2019.01254","article-title":"Functional comparison of blood-stage Plasmodium falciparum malaria vaccine candidate antigens","volume":"10","author":"Illingworth","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2021.100326_bib41","doi-asserted-by":"crossref","first-page":"11802","DOI":"10.1038\/s41598-020-67877-8","article-title":"Bliss\u2019 and Loewe\u2019s additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations","volume":"10","author":"Azasi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2021.100326_bib42","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.celrep.2019.03.020","article-title":"Therapeutic monoclonal antibodies for Ebola virus infection derived from vaccinated humans","volume":"27","author":"Rijal","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2021.100326_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vaccine.2007.10.064","article-title":"Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines","volume":"26","author":"Miura","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2021.100326_bib44","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria","volume":"73","author":"Malkin","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.xcrm.2021.100326_bib45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann. Appl. Biol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121001695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121001695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:47:23Z","timestamp":1762987643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379121001695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2666379121001695"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100326","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100326"}}